Literature DB >> 1553556

Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene.

C Walker1, T L Goldsworthy, D C Wolf, J Everitt.   

Abstract

A single germ line gene mutation at a tumor susceptibility locus in a rodent model of hereditary human renal cancer caused a 70-fold increase in susceptibility to chemical carcinogenesis. A carcinogen that targeted both renal epithelial and mesenchymal cells caused an increase in tumors of epithelial origin in susceptible animals; the number of carcinogen-induced mesenchymal tumors was unaffected by the presence of the mutation at the susceptibility locus. Thus, this mutation defines a genetic locus for susceptibility to carcinogen-induced tumors and modulation of carcinogen susceptibility by this locus exhibits cell-type specificity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553556     DOI: 10.1126/science.1553556

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  Limiting subsequent mutagenic events in carriers of hereditary tumor genes.

Authors:  C E Jackson
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

2.  ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Jaime M C Gard; Raymond B Nagle; Justin D Dietrich; Terrence J Monks; Serrine S Lau
Journal:  Toxicol Sci       Date:  2011-08-02       Impact factor: 4.849

3.  Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.

Authors:  T Soucek; R S Yeung; M Hengstschläger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Time-matched analysis of DNA adduct formation and early gene expression as predictive tool for renal carcinogenesis in methylazoxymethanol acetate treated Eker rats.

Authors:  Valentina Klaus; Heinke Bastek; Katja Damme; Leonard B Collins; Roland Frötschl; Norbert Benda; Dominik Lutter; Heidrun Ellinger-Ziegelbauer; James A Swenberg; Daniel R Dietrich; Kerstin Stemmer
Journal:  Arch Toxicol       Date:  2017-03-27       Impact factor: 5.153

5.  AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability.

Authors:  John D Short; Ruhee Dere; Kevin D Houston; Sheng-Li Cai; Jinhee Kim; Judith M Bergeron; Jianjun Shen; Jiyong Liang; Mark T Bedford; Gordon B Mills; Cheryl Lyn Walker
Journal:  Mol Carcinog       Date:  2010-05       Impact factor: 4.784

6.  Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance.

Authors:  Jennifer D Cook; Barbara J Davis; Sheng-Li Cai; J Carl Barrett; Claudio J Conti; Cheryl Lyn Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

7.  Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10.

Authors:  R S Yeung; K H Buetow; J R Testa; A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors.

Authors:  Kerstin Stemmer; Heidrun Ellinger-Ziegelbauer; Hans-Jürgen Ahr; Daniel R Dietrich
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

9.  AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.

Authors:  John D Short; Kevin D Houston; Ruhee Dere; Sheng-Li Cai; Jinhee Kim; Charles L Johnson; Russell R Broaddus; Jianjun Shen; Susie Miyamoto; Fuyuhiko Tamanoi; David Kwiatkowski; Gordon B Mills; Cheryl Lyn Walker
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

10.  Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.

Authors:  R S Yeung; G H Xiao; F Jin; W C Lee; J R Testa; A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.